<DOC>
	<DOCNO>NCT02276326</DOCNO>
	<brief_summary>Aim study evaluate effect change intestinal microflora neuro-cognitive profile patient HIV infection receive HAART treatment . Improvements evaluate questionnaire Quality life Cognitive Behavior function . 20 patient enrol receive 4 sachet VSL # 3 per day .</brief_summary>
	<brief_title>Effects VSL # 3 Neuro-cognitive Profile HIV Patients</brief_title>
	<detailed_description>The HIV virus mark tropism central nervous system . In 1986 , term AIDS Dementia Complex ( ADC ) coin include single syndrome , whole series severe neurologic manifestation , characterize cognitive , motor behavioral disorder . The introduction HAART lead profound change neurological HIV-mediated profile . The increased morbidity occur HIV patient antiretroviral therapy related inflammatory process cardiovascular disease , result damage mucosa gastrointestinal tract . The massive depletion CD4 T cell GI tract , low frequency CD4 CD8 T produce IL-17 , apoptosis enterocytes ( result structural damage barrier GI tract ) increase intestinal permeability , manifestation progressive HIV infection human . The main consequence structural functional disruption enteric mucosal barrier constitute passage systemic circulation product microbial origin include lipopolysaccharide ( LPS ) , phenomenon know `` microbial translocation '' ( MT ) . A direct consequence MT increase level systemic innate adaptive immune activation . The alteration intestinal mucosa also involve change composition local microbial flora , event change normal balance so-called axis `` brain-gut '' , function axis fact influence metabolic product resident bacterial flora . The disturbance balance cause diseases anxiety depression It 's scientifically proved importance intestinal microflora ( particular bifidobacteria lactobacilli ) play relation multiple task perform , : 1. reduction intraluminal pH production lactic acid , acetic acid organic acid ; 2. production nutrient ( short chain fatty acid , arginine , glutathione , vitamin , etc.. ) extreme importance normal trophism intestinal mucosa ; 3. stimulation immune system particular : macrophage activity , cytokine production , natural killer activity , proliferation lymphocyte , production IgA ; 4. competition pathogen nutrient adhesion gut epithelium ; 5. production bacteriocins ; 6. modulation inflammatory response . The intestinal microflora , therefore , play metabolic activity enormous importance purely nutritional level maintenance efficient barrier activity intestinal mucosa , together modulation local systemic immune response , fundamental protection host organism . VSL # 3 ( original De Simone 's formulation ) probiotic preparation high concentration ( 450 billion bacteria per sachet ) consisting : 4 strain lactobacilli ( L. acidophilus , L. paracasei , L. delbrueckii sub . bulgaricus , L. plantarum ) , 3 strain bifidobacteria : ( B. breve , B. infantis , B. longum ) one strain Streptococcus thermophilus . This product able colonize intestine modulate intestinal microflora . The efficacy VSL # 3 proven treatment inflammatory bowel disease ( ulcerative colitis , pouchitis mainly ) well prevention treatment various gastrointestinal disorder diarrhea rotavirus , traveler 's diarrhea , diarrhea antibiotic therapy radiotherapy . Several study demonstrate efficacy VSL # chronic disease liver ( steatosis , steatohepatitis , NAFLD , etc ... ) . Recently Klatt et al demonstrate treatment antiretroviral ( ARV ) association VSL # 3 dose 225 billion / day ) prebiotics ( inulin ) , period 5 month population macaque result increased reconstruction functionality CD4 + cell reduce fibrosis level lymphoid follicle colon mucosa , compare group macaque treat ARV therapy alone . A decrease immuno-activation CD4 + cell mucosa colon decrease plasma level D-dimers observe macaque treat ARV therapy combination probiotic + prebiotic , compare group control . It good emphasize dimer biomarkers inflammation-related cardiovascular disease HIV patient treat ARV therapy ( Klatt , 2013 ) . All clearly lead improvement immunity gastrointestinal tract , consequent reduction inflammatory process improve prognosis HIV infection . SUB-STUDIES : Given implication chronic immune activation intestinal microbiota alteration HIV-1 disease progression non-AIDS related damage , consider supplement antiretroviral therapy HIV-1 infect patient probiotic mixture might promote beneficial effect restoration HIV related damage intestinal epithelium Gut-Associated Lymphoid Tissue ( GALT ) . To explore potential impact probiotic intestinal damage , design substudy analyze follow parameter : T cell activation CD4+ CD8+ T-cell subset express interferon ( IFN ) Î³ ( Th1 , Tc1 ) interleukin ( IL ) -17A ( Th17 , Tc17 ) multi-parameter flow cytoflorimetric analysis , histological immunohistochemical analysis intestinal biopsy TUNEL assay determine enterocytes apoptosis index .</detailed_description>
	<mesh_term>HIV Seropositivity</mesh_term>
	<criteria>Men woman least 18 year age In HAART HIV RNA &lt; 50cp/mL , CD4 count &gt; 400 cell / mm Availability release inform consent Patients know allergy intolerance VSL # 3 Chronic inflammatory bowel diseases Drug addiction Use antibiotic probiotic 3 week prior enrollment Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>